TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 14 Jul 2023, 12:49 BST

Official UK procurement notice

NP Generic Medicines Transition Tender (October 2023)

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)

Framework agreement4 lotsGoodsOpen procedure
Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)
Framework ceiling (notional)£4,972,000total for 4 lots · framework ceiling, not attributable revenue
Submissions closed 14 Aug 2023awarded 26 Sept 2023
Lots 4see the lot list below

What is being bought4 lots · detail below

Published requirement description

This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
6 bids on the busiest of 4 lots · 7 suppliers appointed

Lots and requirements (4)Procurement structure

4 lots · all with a published value · same evaluation weights on every lot
Lot #1NP35923a ApixabanAwardedPublished value£2,119,925

Supply of Apixaban tablets in a range of presentations.

The Authority will be awarding each product line as a multi-supplier unranked framework agreement to five (5) suppliers awarded to each line.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2NP39723a BexaroteneAwardedPublished value£85,900

Supply of Bexarotene 75mg capsules to NHS Scotland.

The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Variant bids: not allowed
33600000 Pharmaceutical products
Lot #3NP40923a SugammadexAwardedPublished value£2,539,833

Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland.

The Authority will be awarding each line to a single Framework Participant within the single supplier Framework Agreement.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Variant bids: not allowed
33600000 Pharmaceutical products
Lot #4NP36123a AtovaquoneAwardedPublished value£226,333

Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland.

The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.

Delivery: Scotland
Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 4 lots
Quality: 5%Price: 95%
Published sub-criteria (2)
  • API Sources: 5%
  • price: 95%
Published award criteria (2)
  • API Sources: 5
  • Price: 95
Conditions of participation2
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement.

    AND

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    AND

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement should be included in the Qualification Envelo…
What this means for your bid
  • Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NP Generic Medicines Transition Tender (October 2023)” is a framework: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
14 Jul 2023, 12:49 BST
Last source update
26 Sept 2023, 15:13 BST
Award evaluation window
14 Aug 2023 – …
FTS notice number
2023/S 000-028388
Classification (CPV)
Pharmaceutical products
Delivery area
Scotland (UKM)
Official registry OCID
ocds-h6vhtk-03e1fc Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement. For details of individual lines awarded within a Framework Agreement/Lot contact the named person at head of notice. (SC Ref:745745)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
14 Aug 2023, 17:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bid validity
90 days from the deadline
Bids opened
14 Aug 2023, 17:00 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

14 Aug 2023 → 26 Sept 2023 · 3 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    14 Aug 2023, 17:00 BST
  2. Bids opened
    14 Aug 2023, 17:00 BST
  3. Notice published
    26 Sept 2023, 15:13 BST

Notice history

1 event · 2 releases on Find a Tender
  1. Status changed to complete
    26 Sept 2023, 15:13 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 7admitted to the panel · see the list ↓
Bids received 6busiest of 4 lots
Contracts signed 4latest 26 Sept 2023

4 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • NP35923a Apixaban

    Signed
    26 Sept 2023
    Value
    £161,316
    Status
    active

  • NP39723a Bexarotene

    Signed
    26 Sept 2023
    Value
    £35,022
    Status
    active

  • NP36123a Atovaquone

    Signed
    26 Sept 2023
    Value
    £96,219
    Status
    active

  • NP40923a Sugammadex

    Signed
    26 Sept 2023
    Value
    £552,685
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · NP35923a Apixaban5bids · 5 electronic · 5 from abroad0——
2 · NP39723a Bexarotene2bids · 2 electronic · 2 from abroad0——
3 · NP40923a Sugammadex6bids · 6 electronic · 6 from abroad0——
4 · NP36123a Atovaquone1bids · 1 electronic · 1 from abroad0——

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcareBody governed by public lawHealth Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact email, phone Published organisation website ↗

Dispute resolution & review bodies

  • Sheriff Court HouseReview body EdinburghContact email, phone

Framework contractors & participating bidders

7 commercial parties on the notice
  • Celix Pharma Ltd.Framework contractor 12 Constance Street, International House, London, London, E16 2DQContact phone
  • Dr Reddy's Laboratories (UK) LtdFramework contractor 410, Cambridge Science Park,, Milton Road, Milton,, Cambridge, UK, CB4 0PEContact phone
  • Glenmark Pharmaceuticals Europe LtdFramework contractor Building 2, Croxley Green Business Park, Watford, UK, WD18 8YAContact phone
  • Selective Supplies LtdFramework contractor The Priory, Syresham Gardens, Haywards Heath, UK, RH16 3LB
  • Teva UK LtdFramework contractor Ridings Point, Whistler Drive, Glasshoughton, Castleford, UK, WF10 5HXContact phone
  • Thornton & RossFramework contractor Linthwaite, Huddersfield, UK, HD7 5QH
  • Viatris UK Healthcare LtdFramework contractor Building 4, Trident Place, Mosquito Way, Hatfield, East of England, AL10 9ULContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.